Ignite Creation Date:
2025-12-24 @ 12:31 PM
Ignite Modification Date:
2026-02-24 @ 8:27 AM
Study NCT ID:
NCT03681561
Status:
RECRUITING
Last Update Posted:
2025-08-27
First Post:
2018-09-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
Sponsor:
Organization: